<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>2376</billNumber>
    <committeeReports />
    <cboCostEstimates />
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDesc>Introduced in House</actionDesc>
          <updateDate>2017-05-04T04:00:00Z</updateDate>
          <name>Introduced in House</name>
          <lastSummaryUpdateDate>2019-04-15T22:32:23Z</lastSummaryUpdateDate>
          <actionDate>2017-05-04</actionDate>
          <text><![CDATA[<p><b>Drug Diversion and Counterfeit Crackdown Act of 2017</b></p> <p>This bill makes it illegal except in cases of a drug shortage to import into the United States prescription drugs manufactured outside the United States and intended by the manufacturer or labeled to be marketed outside the United States.</p> <p>The bill establishes a penalty for knowingly dispensing or selling a counterfeit drug.</p>]]></text>
        </item>
      </billSummaries>
    </summaries>
    <notes />
    <createDate>2017-05-05T03:11:54Z</createDate>
    <cosponsors>
      <item>
        <bioguideId>D000624</bioguideId>
        <party>D</party>
        <sponsorshipDate>2017-05-04</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <middleName />
        <district>12</district>
        <state>MI</state>
        <fullName>Rep. Dingell, Debbie [D-MI-12]</fullName>
        <lastName>Dingell</lastName>
        <firstName>Debbie</firstName>
        <identifiers>
          <bioguideId>D000624</bioguideId>
          <lisID>2251</lisID>
          <gpoId />
        </identifiers>
      </item>
      <item>
        <bioguideId>B001248</bioguideId>
        <party>R</party>
        <sponsorshipDate>2017-05-04</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <middleName>C.</middleName>
        <district>26</district>
        <state>TX</state>
        <fullName>Rep. Burgess, Michael C. [R-TX-26]</fullName>
        <lastName>Burgess</lastName>
        <firstName>Michael</firstName>
        <identifiers>
          <bioguideId>B001248</bioguideId>
          <gpoId>8182</gpoId>
          <lisID>1751</lisID>
        </identifiers>
      </item>
      <item>
        <bioguideId>G000410</bioguideId>
        <party>D</party>
        <sponsorshipDate>2017-05-04</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <middleName />
        <district>29</district>
        <state>TX</state>
        <fullName>Rep. Green, Gene [D-TX-29]</fullName>
        <lastName>GREEN</lastName>
        <firstName>GENE</firstName>
        <identifiers>
          <lisID>462</lisID>
          <gpoId>8185</gpoId>
          <bioguideId>G000410</bioguideId>
        </identifiers>
      </item>
    </cosponsors>
    <originChamber>House</originChamber>
    <amendments />
    <updateDate>2019-11-15T21:20:58Z</updateDate>
    <relatedBills>
      <item>
        <latestAction>
          <text>Became Public Law No: 115-52.</text>
          <actionDate>2017-08-18</actionDate>
        </latestAction>
        <type>HR</type>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <congress>115</congress>
        <number>2430</number>
        <latestTitle>FDA Reauthorization Act of 2017</latestTitle>
      </item>
      <item>
        <latestAction>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 76.</text>
          <actionDate>2017-05-11</actionDate>
        </latestAction>
        <type>S</type>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <congress>115</congress>
        <number>934</number>
        <latestTitle>FDA Reauthorization Act of 2017</latestTitle>
      </item>
    </relatedBills>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <actionDate>2017-05-05</actionDate>
      <links />
    </latestAction>
    <introducedDate>2017-05-04</introducedDate>
    <laws />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Consumer affairs</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Fraud offenses and financial crimes</name>
          </item>
          <item>
            <name>Manufacturing</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <calendarNumbers />
    <textVersions>
      <item>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr2376ih/xml/BILLS-115hr2376ih.xml</url>
          </item>
        </formats>
        <type>Introduced in House</type>
        <date>2017-05-04T04:00:00Z</date>
      </item>
    </textVersions>
    <version>1.0.0</version>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <recordedVotes />
    <sponsors>
      <item>
        <bioguideId>L000567</bioguideId>
        <state>NJ</state>
        <party>R</party>
        <fullName>Rep. Lance, Leonard [R-NJ-7]</fullName>
        <firstName>Leonard</firstName>
        <lastName>Lance</lastName>
        <identifiers>
          <lisID>1936</lisID>
          <gpoId>8049</gpoId>
          <bioguideId>L000567</bioguideId>
        </identifiers>
        <byRequestType />
        <middleName />
        <district>7</district>
      </item>
    </sponsors>
    <billType>HR</billType>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 163, Number 77 (Thursday, May 4, 2017)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. LANCE:H.R. 2376.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 18, which states that theCongress has the power to make all laws which shall benecessary and proper for carrying into execution theforegoing powers, and all other powers vested by thisConstitution in the government of the United States or in anydepartment or officer thereof.[Page H4179]</pre>]]></constitutionalAuthorityStatementText>
    <title>Drug Diversion and Counterfeit Crackdown Act of 2017</title>
    <congress>115</congress>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <subcommittees>
            <item>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-05-05T20:23:45Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-05-04T13:01:15Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2017-05-05</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2017-05-04</actionDate>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <links />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to the House Committee on Energy and Commerce.</text>
      </item>
      <item>
        <actionDate>2017-05-04</actionDate>
        <committee />
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
      </item>
      <item>
        <actionDate>2017-05-04</actionDate>
        <committee />
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
      </item>
      <actionTypeCounts>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
        <placeholderTextForH>1</placeholderTextForH>
        <billReferrals>1</billReferrals>
      </actionTypeCounts>
    </actions>
    <titles>
      <item>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to protect and strengthen the drug supply chain in the United States by closing several statutory gaps in the penalty provisions of such Act that apply to drug diversion and counterfeiting.</title>
        <chamberCode />
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
      </item>
      <item>
        <title>Drug Diversion and Counterfeit Crackdown Act of 2017</title>
        <chamberCode />
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
      </item>
      <item>
        <title>Drug Diversion and Counterfeit Crackdown Act of 2017</title>
        <chamberCode />
        <parentTitleType />
        <titleType>Display Title</titleType>
        <chamberName />
      </item>
      <item>
        <title>Drug Diversion and Counterfeit Crackdown Act of 2017</title>
        <chamberCode />
        <parentTitleType />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberName />
      </item>
    </titles>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

